Ventures Acacia Pharma 22. oktober 2019 Issue of Equity on Exercise of Options/Vesting of Performance Share Awards Bonesupport 30. september 2019 Change in number of shares and votes in BONESUPPORT HOLDING AB (publ) Acacia Pharma 26. september 2019 Acacia Pharma Group PLC – Acacia Pharma Announces New BARHEMSYS® PDUFA Target Date of 26 February 2020 Sanifit 23. september 2019 Sanifit named as one of 2019’s “Fierce 15” biotechnology companies by FierceBiotech Bonesupport 19. september 2019 BONESUPPORT HOLDING AB presents health economic evidence Acacia Pharma 17. september 2019 Acacia Pharma Group plc – Issue of Equity on Exercise of Options/Vesting of Performance Share Awards Amplyx Pharmaceuticals 17. september 2019 Amplyx Pharmaceuticals Licenses Phase 2 Drug Candidate for BK Viral Disease in Transplant Patients Amplyx Pharmaceuticals 17. september 2019 Amplyx Pharmaceuticals Announces Positive Preliminary Data from Ongoing Fosmanogepix Phase 2 Study in Candidemia Amplyx Pharmaceuticals 10. september 2019 FDA Grants Fast Track Status to Amplyx Pharmaceuticals for IV and Oral Formulations of Fosmanogepix (APX001) for Seven Different Indications Acacia Pharma 5. september 2019 Acacia Pharma Group plc – Interim Results for the Six Months ended 30 June 2019 Sideinddeling Første side « Første Forrige side ‹‹ … Side 5 Side 6 Side 7 Side 8 Nuværende side 9 Side 10 Side 11 Side 12 Side 13 … Næste side ›› Sidste side Sidste »
